Literature DB >> 17494895

Novartis suspends tegaserod sales at FDA's request.

Cheryl A Thompson.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17494895     DOI： 10.2146/news070044

Source DB:  PubMed          Journal:  Am J Health Syst Pharm        ISSN： 1079-2082            Impact factor:   2.637


× No keyword cloud information.
  15 in total

Review 1.  Diagnosis and management of IBS.

Authors:  Sarah Khan; Lin Chang
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-10       Impact factor: 46.802

Review 2.  New treatments for IBS.

Authors:  Magnus Halland; Nicholas J Talley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-11-13       Impact factor: 46.802

Review 3.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

4.  Irritable bowel syndrome: current and emerging treatment options.

Authors:  Lauren Peyton; Joy Greene
Journal:  P T       Date:  2014-08

Review 5.  Bloating and functional gastro-intestinal disorders: where are we and where are we going?

Authors:  Paola Iovino; Cristina Bucci; Fabrizio Tremolaterra; Antonella Santonicola; Giuseppe Chiarioni
Journal:  World J Gastroenterol       Date:  2014-10-21       Impact factor: 5.742

6.  Prucalopride: the evidence for its use in the treatment of chronic constipation.

Authors:  Georges Coremans
Journal:  Core Evid       Date:  2008-06

Review 7.  Complementary and alternative medicines in irritable bowel syndrome: an integrative view.

Authors:  Oliver Grundmann; Saunjoo L Yoon
Journal:  World J Gastroenterol       Date:  2014-01-14       Impact factor: 5.742

Review 8.  Recent advances in pharmacological treatment of irritable bowel syndrome.

Authors:  Georgia Lazaraki; Grigoris Chatzimavroudis; Panagiotis Katsinelos
Journal:  World J Gastroenterol       Date:  2014-07-21       Impact factor: 5.742

9.  Pharmacologic and complementary and alternative medicine therapies for irritable bowel syndrome.

Authors:  William D Chey; Monthira Maneerattaporn; Richard Saad
Journal:  Gut Liver       Date:  2011-08-18       Impact factor: 4.519

10.  Current trends in the management of gastroesophageal reflux disease: a review.

Authors:  Sylvester Chuks Nwokediuko
Journal:  ISRN Gastroenterol       Date:  2012-07-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.